phenotype

NEUROINFLAMMATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROINFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11063Connections
0Hypotheses
25Analyses
50Outgoing
50Incoming
0Experiments
20Debates

Summary

NEUROINFLAMMATION is a phenotype associated with neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with AD, ALS, ALZHEIMER. Connected to 2614 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Microglia in Chronic Neuroinflammation

cell · 1202 words

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Als["Als"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Neuroinflammation_1["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Inflammation_2["Inflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Autophagy["Autophagy"]
        CYTOKINES["CYTOKINES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    subgraph Pathology["Pathology"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Inflammation["Inflammation"]
        APOE["APOE"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        APP["APP"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (4386)

TargetRelationTypeStr
Micrornaregulatespathway1.00
Strokeactivatesdisease1.00
Alzheimercontributes_todisease1.00
Alzheimercausesdisease1.00
Inflammationtherapeutic_targetdisease1.00

Incoming (6677)

SourceRelationTypeStr
entities-complement-systeminvolved_inwiki0.00
entities-microglia-in-neurodegenerationinvolved_inwiki0.00
Parkinsonactivatesdisease1.00
CYTOKINESregulatesgene1.00
STROKEactivatesgene1.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (25)

Scientific analyses that reference this entity

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 0 hypotheses

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

neuroinflammation | 2026-04-16 | 5 hypotheses Top: 0.599

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.919

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 7 hypotheses Top: 0.728

What molecular mechanisms drive the transition from acute to persistent neuroinf

neuroinflammation | 2026-04-15 | 2 hypotheses Top: 0.601

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (20)

Multi-agent debates referencing this entity

Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat

closed · Rounds: 4 · Score: 0.76 · 2026-04-23

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Analysis for knowledge gap 006 in the neurodegeneration domain.

closed · Rounds: 4 · Score: 0.79 · 2026-04-22

What is the current clinical trial landscape for AD therapeutics, and which mech

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Is the amyloid concentration in AD clinical trials rational given lecanemab's ap

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The abstract reports that Alectinib binds C1q with high affinity, but this is me

closed · Rounds: 4 · Score: 0.94 · 2026-04-16

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

closed · Rounds: 7 · Score: 0.87 · 2026-04-16

The abstract shows that acute neuroinflammation becomes persistent with a specif

closed · Rounds: 4 · Score: 0.83 · 2026-04-15

The abstract shows TYROBP deficiency is neuroprotective despite being required f

closed · Rounds: 4 · Score: 0.56 · 2026-04-15